Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome.

Jarrett ME, Cain KC, Barney PG, Burr RL, Naliboff BD, Shulman R, Zia J, Heitkemper MM.

J Neurogastroenterol Motil. 2016 Jan 31;22(1):102-11. doi: 10.5056/jnm15067.

2.

Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.

Everitt H, Landau S, Little P, Bishop FL, McCrone P, O'Reilly G, Coleman N, Logan R, Chalder T, Moss-Morris R; ACTIB trial team.

BMJ Open. 2015 Jul 15;5(7):e008622. doi: 10.1136/bmjopen-2015-008622.

3.

Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease.

Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW.

PLoS One. 2015 Apr 30;10(4):e0123861. doi: 10.1371/journal.pone.0123861. eCollection 2015.

4.

Study design considerations for irritable bowel syndrome clinical trials.

Miller LE.

Ann Gastroenterol. 2014;27(4):338-345. Review.

5.

Irritable bowel syndrome: a clinical review.

Soares RL.

World J Gastroenterol. 2014 Sep 14;20(34):12144-60. doi: 10.3748/wjg.v20.i34.12144. Review.

6.

Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome.

Muscatello MR, Bruno A, Scimeca G, Pandolfo G, Zoccali RA.

World J Gastroenterol. 2014 Jun 28;20(24):7570-86. doi: 10.3748/wjg.v20.i24.7570. Review.

7.

A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndrome.

Dainty AD, Fox M, Lewis N, Hunt M, Holtham E, Timmons S, Kinsella P, Wragg A, Callaghan P.

BMJ Open. 2014 Jun 17;4(6):e005262. doi: 10.1136/bmjopen-2014-005262.

8.

Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Grundmann O, Yoon SL.

World J Gastroenterol. 2014 Jan 14;20(2):346-62. doi: 10.3748/wjg.v20.i2.346. Review.

9.

Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Tang QL, Lin GY, Zhang MQ.

World J Gastroenterol. 2013 Dec 14;19(46):8605-10. doi: 10.3748/wjg.v19.i46.8605. Review.

10.

GP perspectives of irritable bowel syndrome--an accepted illness, but management deviates from guidelines: a qualitative study.

Harkness EF, Harrington V, Hinder S, O'Brien SJ, Thompson DG, Beech P, Chew-Graham CA.

BMC Fam Pract. 2013 Jun 27;14:92. doi: 10.1186/1471-2296-14-92.

11.

Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.

Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, Smith P, Little P.

BMC Gastroenterol. 2013 Apr 21;13:68. doi: 10.1186/1471-230X-13-68.

12.

Current and emerging therapies for the management of functional gastrointestinal disorders.

Craig OF, Quigley EM.

Ther Adv Chronic Dis. 2011 Mar;2(2):87-99. doi: 10.1177/2040622310389507.

13.

A protocol for a trial of homeopathic treatment for irritable bowel syndrome.

Peckham EJ, Relton C, Raw J, Walters C, Thomas K, Smith C.

BMC Complement Altern Med. 2012 Nov 6;12:212. doi: 10.1186/1472-6882-12-212.

14.

Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.

Sinagra E, Romano C, Cottone M.

Gastroenterol Res Pract. 2012;2012:486067. doi: 10.1155/2012/486067. Epub 2012 Aug 22.

15.

Functional bowel disorders in adults.

Häuser W, Layer P, Henningsen P, Kruis W.

Dtsch Arztebl Int. 2012 Feb;109(5):83-94. doi: 10.3238/arztebl.2012.0083. Epub 2012 Feb 3.

16.

Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran.

Modabbernia MJ, Mansour-Ghanaei F, Imani A, Mirsafa-Moghaddam SA, Sedigh-Rahimabadi M, Yousefi-Mashhour M, Joukar F, Atrkar-Roushan Z, Bidel S.

BMC Res Notes. 2012 Feb 21;5:112. doi: 10.1186/1756-0500-5-112.

17.

Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study.

Bafeta A, Dechartres A, Trinquart L, Yavchitz A, Boutron I, Ravaud P.

BMJ. 2012 Feb 14;344:e813. doi: 10.1136/bmj.e813.

18.

Managing pain in inflammatory bowel disease.

Docherty MJ, Jones RC 3rd, Wallace MS.

Gastroenterol Hepatol (N Y). 2011 Sep;7(9):592-601.

19.

Irritable bowel syndrome.

Ford AC, Vandvik PO.

BMJ Clin Evid. 2012 Jan 6;2012. pii: 0410.

20.

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).

Flik CE, van Rood YR, Laan W, Smout AJ, Weusten BL, Whorwell PJ, de Wit NJ.

BMC Gastroenterol. 2011 Dec 20;11:137. doi: 10.1186/1471-230X-11-137.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk